Sarah Rowland-Jones qualified in medicine from Cambridge and Oxford Universities, and trained in Infectious Diseases in London and Oxford. Her research career began in Oxford with a doctorate supervised by Professor Andrew McMichael on the role of cellular immune responses to viral infections, focusing on the T-cell response to HIV-1 infection and how viral evolution
Sarah Rowland-Jones qualified in medicine from Cambridge and Oxford Universities, and trained in Infectious Diseases in London and Oxford. Her research career began in Oxford with a doctorate supervised by Professor Andrew McMichael on the role of cellular immune responses to viral infections, focusing on the T-cell response to HIV-1 infection and how viral evolution can lead to evasion of this response. Since 1995 she has led a research group in the MRC Human Immunology Unit in Oxford, studying the role played by cytotoxic T-cells in determining the outcome of HIV infection, as well as dengue and influenza virus infections. A key focus of the work has been the study of immune responses to HIV in people with an unusually good outcome of their exposure to the virus, in collaboration with investigators in the Gambia, Kenya, USA, Viet Nam and China. Between 2004 and 2008 she was Director of Research of the MRC Laboratories, the Gambia, the UK’s oldest and largest overseas research unit, changing her research focus towards the pathogenesis of HIV-2 infection in West Africa. She recently returned to Oxford as an MRC Research professor. She is an Honorary Consultant in Infectious Diseases at the Churchill Hospital and a Fellow of Christ Church, Oxford.
